Swiss National Bank Eagle Pharmaceuticals, Inc. Transaction History

Swiss National Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$25.06 - $34.09 $90,216 - $122,724	-3,600 Reduced 12.46%	25,300 $717,000
Q4 2022 Feb 08, 2023	BUY	$24.98 - $39.77 $22,482 - $35,793	900 Added 3.21%	28,900 $844,000
Q2 2022 Aug 09, 2022	BUY	$41.26 - $51.35 $82,520 - $102,700	2,000 Added 7.69%	28,000 $1.24 Million
Q1 2022 May 09, 2022	BUY	$44.58 - $52.6 $71,328 - $84,160	1,600 Added 6.56%	26,000 $1.29 Million
Q2 2021 Aug 06, 2021	SELL	$36.86 - $44.5 $33,174 - $40,050	-900 Reduced 3.56%	24,400 $1.04 Million
Q1 2021 May 07, 2021	SELL	$40.32 - $50.97 $44,352 - $56,067	-1,100 Reduced 4.17%	25,300 $1.06 Million
Q3 2020 Nov 09, 2020	BUY	$37.02 - $51.28 $18,510 - $25,640	500 Added 1.93%	26,400 $1.12 Million
Q2 2020 Aug 05, 2020	BUY	$43.24 - $55.02 $203,228 - $258,594	4,700 Added 22.17%	25,900 $1.24 Million
Q1 2020 May 08, 2020	BUY	$34.37 - $60.07 $13,747 - $24,028	400 Added 1.92%	21,200 $975,000
Q2 2019 Aug 02, 2019	SELL	$46.61 - $58.45 $23,305 - $29,225	-500 Reduced 2.35%	20,800 $1.16 Million
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $22,032 - $40,638	600 Added 2.9%	21,300 $858,000
Q2 2018 Aug 09, 2018	BUY	$51.25 - $76.62 $333,125 - $498,030	6,500 Added 45.77%	20,700 $1.57 Million
Q3 2017 Nov 03, 2017	BUY	$46.62 - $60.36 $662,004 - $857,112	14,200	14,200 $847,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.